Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: Molecular Signatures of Esophageal Atresia [NA]

View source ↗

Summary

A completed clinical trial from University Hospital, Lille examining molecular signatures in Esophageal Atresia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Lille | Conditions: Esophageal Atresia | NA | Status: COMPLETED